Skip to main content
. 2020 Mar 12;121(8):1225–1232. doi: 10.1002/jso.25897

Table 1.

General characteristics of the study cohort

Sex (N)
Male 20 (40%)
Female 30 (60%)
Age
Median 65 y
Range 62‐80 y
Comorbidities
Pulmonary
COPD (PFT – FEV1 predicted percentage range) 33‐130
Mild 2 (4%)
Moderate 12 (24%)
Severe 4 (8%)
Cardiac
Non‐ischemic cardiomyopathy 32 (64%)
CAD 2 (4%)
Hypertension 21 (42%)
Prior cancer history
• Squamous cell carcinoma of the skin 2 (4%)
• Bladder cancer 2 (4%)
• Breast cancer 14 (28%)
• Lung cancer 3 (6%)
• Leukemia/Lymphoma 3 (6%)
• Melanoma 8 (16%)
• Ovarian cancer 2 (4%)
• Sarcoma 1 (2%)
Smoking history (N)
• ≥30 pack‐years 1 (2%)
• Quit>15 y ago 1 (25)
• <30 pack‐years 27 (68%)
• Current smokers 4 (8%)
• Never smokers 17 (34%)
Family history of cancer 17 (34%)
Nodule Characteristics
• Nodule size 0.6‐2.7 cm
• Distance to the pleura 0‐4.2 cm (mean = 1.3 ± 0.38 cm)
• <1 cm 29 (43%)
• 1‐2 cm 13 (26%)
• 2 cm 8 (16%)
Nodule location
• Left lower lobe 8 (16%)
• Left upper lobe 9 (18%)
• Lingula 2 (4%)
• Right middle lobe 1 (2%)
• Right upper lobe 19 (48%)
• Right lower lobe 11 (22)
Technical factors associated with the study
Number of scans 46 (1 scan)
4 (2 scans)
Induction to incision (median; range) 89 min (13‐256 min)
Time for T‐bar placement (median; range) 13.5 min (14‐29 min)
Incision to closure time (median; range) 107 min (41‐302 min)
Radiation exposure (median; range) 6 mSv; range: 2.9‐35 mSv
Length of stay (N; range) 3 d, (1‐12 d)
Type of surgery
• Wedge resection • 48 (89%)
• Lobectomy • 4 (7%)
• Segmentectomy • 2 (4%)
• Lymph node dissection • 45 (90%)